PCSK9 pipeline

被引：0
|
作者：
Mullard, Asher
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 12期
关键词：
D O I：
10.1038/nrd.2016.258
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：811 / 811
页数：1
相关论文
共 50 条
  • [21] Targeting PCSK9 for Hypercholesterolemia
    Norata, Giuseppe Danilo
    Tibolla, Gianpaolo
    Catapano, Alberico Luigi
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 273 - 293
  • [22] PCSK9 Mediates Atherogenesis
    Sun, Hua
    Krauss, Ronald M.
    Teng, Ba-bie
    CIRCULATION, 2016, 134
  • [23] PCSK9 and its modulation
    Cui, Chuan-Jue
    Li, Sha
    Li, Jian-Jun
    CLINICA CHIMICA ACTA, 2015, 440 : 79 - 86
  • [24] PCSK9: An enigmatic protease
    Lopez, Dayami
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2008, 1781 (04): : 184 - 191
  • [25] Access to PCSK9 Inhibitors
    Baum, Seth J.
    Lepor, Norman E.
    Robinson, Jennifer G.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S47 - S50
  • [26] PCSK9 inhibitors are go
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 593 - 593
  • [27] PCSK9 inhibition in PAD
    Karina Huynh
    Nature Reviews Cardiology, 2018, 15 : 4 - 5
  • [28] Oral PCSK9 Inhibitors
    Anandita Agarwala
    Ramsha Asim
    Christie M. Ballantyne
    Current Atherosclerosis Reports, 2024, 26 : 147 - 152
  • [29] The Multifaceted Biology of PCSK9
    Seidah, Nabil G.
    Prat, Annik
    ENDOCRINE REVIEWS, 2021, 43 (03) : 558 - 582
  • [30] Oral PCSK9 Inhibitors
    Agarwala, Anandita
    Asim, Ramsha
    Ballantyne, Christie M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (05) : 147 - 152
12345